Retrospective Trials, In Progess
2023
Study: Brain Metastasis from Cholangiocarcinoma
PI: Yavuz Samanci
IRRF Member: Selcuk Peker
IRRF Center: Koc University
Study: Radiosurgery for Pleomorphic Xanthoastrocytoma
PI: Yavuz Samanci
IRRF Member: Selcuk Peker
IRRF Center: Koc University
Study: Stereotactic radiosurgery for hemangioblastoma
PI: Ahmed Shaaban
IRRF Member: Sheehan
IRRF Center: UVA
Study: Assessing outcomes after SRS in patients with tumor-related TN
PI: Timoteo Almeida
IRRF Member: Carolina Benjamin
IRRF Center: UMiami
Study: Proposal for IRRF and CONDOR low-grade dAVFs Project
PI: Ching-Jen Chen
IRRF Member: Ching-Jen Chen
IRRF Center: UTexas
Study: Dosimetric Predictors of Toxicity for Brainstem Mets, AVMs, and large VS
PI: Raj Singh
IRRF Member: Sheehan
IRRF Center: UVA
Study: Calculate Dose Rate from the “SEALED SOURCE TEST CERTIFICATE”:
PI: Tanxia Qu
IRRF Member: Kondziolka
IRRF Center: NYU
Study: Brain Metastases from Sarcoma Primaries
PI: Raj Singh
IRRF Member: Sheehan
IRRF Center: UVA
Study: Safety and Efficacy of a Third SRS for Recurrent Trigeminal Neuralgia
PI: Fernando
IRRF Member: Sheehan
IRRF Center: UVA
Study: SRS for Pituitary Metastases
PI: Sam
IRRF Member: Lunsford
IRRF Center: UPMC
2022
Study: 5-factor Modified Frailty Index as a Predictor of Outcomes for metastases SRS
PI: Shahed Elhamdani
IRRF Member: Shepard
RRF Center: AGH
Study: Topography of Brain Metastases by Primary Cancer Genetic Subtypes
PI: Gabriel Zada
IRRF Member: Zada
IRRF Center: USC
Study: Pre vs Postoperative SRS for Brain Metastases
PI: Rodney Wegner
IRRF Member: Shepard
IRRF Center: AGH
Study: Outcome of 1 versus 20 or More Brain Metastases SRS
PI: Zhishuo Wei
IRRF Member: Niranjan
IRRF Center: UPMC
Study: Single Fraction versus Multi-Fraction SRS for Large Brain Metastases
PI: Eric J. Lehrer
IRRF Member: Sheehan
IRRF Center: UVA
Study: Ki-67 as a predictor of meningiomas SRS
PI: Mittal AM
IRRF Member: Lunsford
IRRF Center: UPMC
Study: Outcomes after SRS for Intraventricular Meningiomas
PI: Alberto Daza-Ovalle
IRRF Member: Niranjan
IRRF Center: UPMC
Study: Stereotactic Radiosurgery for cerebral cavernous malformations.
PI: Chloé Dumot
IRRF Member: Sheehan
IRRF Center: UVA
Study: Telemedicine in Stereotactic Radiosurgery Patient Populations
PI: Christopher P. Cifarelli
IRRF Member: Cifarelli
IRRF Center: WVU
Study: Intra-tumoral Hemorrhage in Vestibular Schwannomas After SRS
PI: Othman Bin-Alamer
IRRF Member: Lunsford
IRRF Center: UPMC
Study: Assessing long term risk of pituitary adenoma radiosurgery
PI: Sam Dayawansa
IRRF Member: Sheehan
IRRF Center: UVA
Study: SRS for MS-Related Trigeminal Neuralgia
PI: Doug Kondziolka
IRRF Member: Kondziolka
IRRF Center: NYU
Study: SRS for papillary tumors of the pineal
PI: Jean-Nicolas Tourigny
IRRF Member: Mathieu
IRRF Center: UdS
Study: SRS for Pineocytoma
PI: Jean-Nicolas Tourigny
IRRF Member: Mathieu
IRRF Center: UdS
Study: SRS vs. Observation for the Management of Vestibular Schwannomas
PI: Sheehan
IRRF Member: Sheehan
IRRF Center: UVA
Study: Brain Metastasis from Cholangiocarcinoma
PI: Yavuz Samanci
IRRF Member: Selcuk Peker
IRRF Center: Koc University
Study: Radiosurgery for Pleomorphic Xanthoastrocytoma
PI: Yavuz Samanci
IRRF Member: Selcuk Peker
IRRF Center: Koc University
Study: Stereotactic radiosurgery for hemangioblastoma
PI: Ahmed Shaaban
IRRF Member: Sheehan
IRRF Center: UVA
Study: Assessing outcomes after SRS in patients with tumor-related TN
PI: Timoteo Almeida
IRRF Member: Carolina Benjamin
IRRF Center: UMiami
Study: Proposal for IRRF and CONDOR low-grade dAVFs Project
PI: Ching-Jen Chen
IRRF Member: Ching-Jen Chen
IRRF Center: UTexas
Study: Dosimetric Predictors of Toxicity for Brainstem Mets, AVMs, and large VS
PI: Raj Singh
IRRF Member: Sheehan
IRRF Center: UVA
Study: Calculate Dose Rate from the “SEALED SOURCE TEST CERTIFICATE”:
PI: Tanxia Qu
IRRF Member: Kondziolka
IRRF Center: NYU
Study: Brain Metastases from Sarcoma Primaries
PI: Raj Singh
IRRF Member: Sheehan
IRRF Center: UVA
Study: Safety and Efficacy of a Third SRS for Recurrent Trigeminal Neuralgia
PI: Fernando
IRRF Member: Sheehan
IRRF Center: UVA
Study: SRS for Pituitary Metastases
PI: Sam
IRRF Member: Lunsford
IRRF Center: UPMC
2022
Study: 5-factor Modified Frailty Index as a Predictor of Outcomes for metastases SRS
PI: Shahed Elhamdani
IRRF Member: Shepard
RRF Center: AGH
Study: Topography of Brain Metastases by Primary Cancer Genetic Subtypes
PI: Gabriel Zada
IRRF Member: Zada
IRRF Center: USC
Study: Pre vs Postoperative SRS for Brain Metastases
PI: Rodney Wegner
IRRF Member: Shepard
IRRF Center: AGH
Study: Outcome of 1 versus 20 or More Brain Metastases SRS
PI: Zhishuo Wei
IRRF Member: Niranjan
IRRF Center: UPMC
Study: Single Fraction versus Multi-Fraction SRS for Large Brain Metastases
PI: Eric J. Lehrer
IRRF Member: Sheehan
IRRF Center: UVA
Study: Ki-67 as a predictor of meningiomas SRS
PI: Mittal AM
IRRF Member: Lunsford
IRRF Center: UPMC
Study: Outcomes after SRS for Intraventricular Meningiomas
PI: Alberto Daza-Ovalle
IRRF Member: Niranjan
IRRF Center: UPMC
Study: Stereotactic Radiosurgery for cerebral cavernous malformations.
PI: Chloé Dumot
IRRF Member: Sheehan
IRRF Center: UVA
Study: Telemedicine in Stereotactic Radiosurgery Patient Populations
PI: Christopher P. Cifarelli
IRRF Member: Cifarelli
IRRF Center: WVU
Study: Intra-tumoral Hemorrhage in Vestibular Schwannomas After SRS
PI: Othman Bin-Alamer
IRRF Member: Lunsford
IRRF Center: UPMC
Study: Assessing long term risk of pituitary adenoma radiosurgery
PI: Sam Dayawansa
IRRF Member: Sheehan
IRRF Center: UVA
Study: SRS for MS-Related Trigeminal Neuralgia
PI: Doug Kondziolka
IRRF Member: Kondziolka
IRRF Center: NYU
Study: SRS for papillary tumors of the pineal
PI: Jean-Nicolas Tourigny
IRRF Member: Mathieu
IRRF Center: UdS
Study: SRS for Pineocytoma
PI: Jean-Nicolas Tourigny
IRRF Member: Mathieu
IRRF Center: UdS
Study: SRS vs. Observation for the Management of Vestibular Schwannomas
PI: Sheehan
IRRF Member: Sheehan
IRRF Center: UVA